Your browser doesn't support javascript.
loading
Bioavailability of oral vs. subcutaneous low-dose methotrexate in patients with Crohn's disease.
Kurnik, D; Loebstein, R; Fishbein, E; Almog, S; Halkin, H; Bar-Meir, S; Chowers, Y.
Affiliation
  • Kurnik D; Division of Clinical Pharmacology and Toxicology, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Aliment Pharmacol Ther ; 18(1): 57-63, 2003 Jul 01.
Article in En | MEDLINE | ID: mdl-12848626
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Crohn Disease / Methotrexate Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2003 Document type: Article Affiliation country: Israel Country of publication: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Crohn Disease / Methotrexate Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2003 Document type: Article Affiliation country: Israel Country of publication: Reino Unido